Xian L - Search Results

1

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN.

He W, Long J, Xian L, Pang F, Su L, Wei S, Wei B, Hu Y. He W, et al. Among authors: xian l. Exp Ther Med. 2012 Oct;4(4):569-576. doi: 10.3892/etm.2012.640. Epub 2012 Jul 18. Exp Ther Med. 2012. PMID: 23170107 Free PMC article.

2

ADIPOQ gene polymorphisms and susceptibility to polycystic ovary syndrome: a HuGE survey and meta-analysis.

Xian L, He W, Pang F, Hu Y. Xian L, et al. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):117-24. doi: 10.1016/j.ejogrb.2011.12.017. Epub 2012 Jan 11. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22239938 Review.

3

[Screening key genes associated with the development and progression of non-small cell lung cancer based on gene-enrichment analysis and meta-analysis].

He W, Xian L, Wang Y, Hu Y, Chen M. He W, et al. Among authors: xian l. Zhongguo Fei Ai Za Zhi. 2012 Jul;15(7):416-21. doi: 10.3779/j.issn.1009-3419.2012.07.05. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22814261 Free PMC article. Chinese.

4

Natural selection and functional diversification of the epidermal growth factor receptor EGFR family in vertebrates.

Liu Y, He W, Long J, Pang F, Xian L, Chen M, Wu Y, Hu Y. Liu Y, et al. Among authors: xian l. Genomics. 2013 Jun;101(6):318-25. doi: 10.1016/j.ygeno.2013.03.001. Epub 2013 Mar 14. Genomics. 2013. PMID: 23499669 Free article.

5

Key genes and pathways in thyroid cancer based on gene set enrichment analysis.

He W, Qi B, Zhou Q, Lu C, Huang Q, Xian L, Chen M. He W, et al. Among authors: xian l. Oncol Rep. 2013 Sep;30(3):1391-7. doi: 10.3892/or.2013.2557. Epub 2013 Jun 20. Oncol Rep. 2013. PMID: 23784086

6

Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.

Tan X, Wang Y, Shi L, Xian L, Guo J, Liang G, Chen M. Tan X, et al. Among authors: xian l. Genet Test Mol Biomarkers. 2014 Jan;18(1):50-6. doi: 10.1089/gtmb.2013.0296. Epub 2013 Oct 1. Genet Test Mol Biomarkers. 2014. PMID: 24083550

7

Association between ERCC2 Lys751Gln polymorphism and lung cancer risk: a meta-analysis involving 23,370 subjects.

Tan X, Xian L, Chen X, Shi L, Wang Y, Guo J, Liang G, Zhao Z, Chen M. Tan X, et al. Among authors: xian l. Twin Res Hum Genet. 2014 Apr;17(2):99-107. doi: 10.1017/thg.2014.4. Epub 2014 Feb 20. Twin Res Hum Genet. 2014. PMID: 24556168

8

Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis.

Yang Y, Xie Y, Xian L. Yang Y, et al. Among authors: xian l. J Exp Clin Cancer Res. 2013 Mar 15;32(1):15. doi: 10.1186/1756-9966-32-15. J Exp Clin Cancer Res. 2013. PMID: 23497550 Free PMC article. Review.

9

The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.

Yang Y, Xian L. Yang Y, et al. Among authors: xian l. Tumour Biol. 2014 Apr;35(4):2905-21. doi: 10.1007/s13277-013-1493-5. Epub 2013 Dec 13. Tumour Biol. 2014. PMID: 24338713 Review.

10

The prognostic role of the class III β-tubulin in non-small cell lung cancer (NSCLC) patients receiving the taxane/vinorebine-based chemotherapy: a meta-analysis.

Yang YL, Luo XP, Xian L. Yang YL, et al. Among authors: xian l. PLoS One. 2014 Apr 4;9(4):e93997. doi: 10.1371/journal.pone.0093997. eCollection 2014. PLoS One. 2014. PMID: 24705847 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters